February 19, 2021
Article
Noncompliance among younger patients and lack of education are issues that should continually be addressed by care teams.
February 18, 2021
In a Q&A, 2 ophthalmologists provide an overview and offer some perspective on the risks and heritability associated with glaucoma.
February 17, 2021
The number of individuals suffering from vision impairment expected to rise to 895 million by 2050.
February 16, 2021
No approved treatment for leber hereditary optic neuropathy is currently available in the United States.
February 12, 2021
The company plans to submit the data to the FDA and EMA for consideration of the injectable bispecific antibody's regulatory approval for the treatment of both conditions.
February 11, 2021
This approval was granted to generic pharmaceutical company Akorn Operating Company, LLC.
February 04, 2021
Hydroxyurea therapy was associated with decreased rates of retinal thinning and could be a protective factor.
February 01, 2021
Eysuvis 0.25% is the first and only approved prescription therapy for short-term treatment of signs and symptoms related to dry eye disease.
January 29, 2021
Low and moderate dosing shows the most potential in preventing AMD for patients with diabetes.
January 25, 2021
Patients treated with the bispecific antibody at fixed intervals of 16 weeks achieved visual acuity outcomes comparable to 8-week interval treatment of aflibercept.
